Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31090251 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| Hexaethylene Glycol SCHEMBL6324969 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL888101 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL12469395 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL12469742 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL197305 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL12469885 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL9361385 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL12469729 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL4431897 | 0.97 | TSHR (0.53) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115872877-A | Synthesis method of aminotetraethyleneglycol | 南京安伦化工科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| EP-1592779-A4 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS | GE HEALTHCARE BIO SCIENCES (US) | 2007-12-12 | — | — | EP | claimed |
| EP-1592779-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS | Amersham Biosciences Corp. (US) | 2005-11-09 | — | — | EP | claimed |
| US-20040241716-A1 | Terminal-phosphate-labeled nucleotides with new linkers | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2004-12-02 | — | — | US | claimed |
| WO-2004072238-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS | AMERSHAM BIOSCIENCES CORP (US) | 2004-08-26 | — | — | WO | claimed |
| EP-0449419-B1 | Hydroxy terminated polyamides | TEXACO CHEMICAL (US) | 1994-08-10 | — | — | EP | claimed |
| US-5130382-A | Amine terminated polyethers reacted with a diacid to form hydroxy terminated polyamides for forming polyurethanes | TEXACO CHEMICAL COMPANY (US) | 1992-07-14 | — | — | US | claimed |
| EP-0449419-A1 | Hydroxy terminated polyamides | Huntsman Corporation (US) | 1991-10-02 | — | — | EP | claimed |
| EP-0439208-A2 | Method and kits for detecting human leukocyte antigen DNA | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-07-31 | — | — | EP | claimed |
| EP-4199179-B1 | POSITIVE ELECTRODE ACTIVE MATERIAL, POSITIVE ELECTRODE AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2026-03-11 | — | — | EP | disclosed |
| US-12498367-B2 | Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof | CYTOMX THERAPEUTICS, INC. | 2025-12-16 | — | — | US | disclosed |
| CN-223504836-U | Amino tetraethylene glycol enrichment facility | 南京安伦化工科技有限公司 | 2025-11-04 | — | — | CN | disclosed |
| CN-118930835-A | Double-protection amino polyethylene glycol and derivative and preparation method thereof | 中国科学院长春应用化学研究所 | 2024-11-12 | — | — | CN | disclosed |
| WO-2024212960-A1 | ANTI-TROP2 ANTIBODY-NATURAL KILLER CELL CONJUGATE AND USE THEREOF | 英百瑞(杭州)生物医药有限公司 | 2024-10-17 | — | — | WO | disclosed |
| EP-0449419-A1 | Hydroxy terminated polyamides | Huntsman Corporation (US) | 1991-10-02 | — | — | EP | disclosed |
| EP-0439208-A2 | Method and kits for detecting human leukocyte antigen DNA | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-07-31 | — | — | EP | disclosed |
| EP-0437981-A1 | Polyamide-esters, processes for the manufacture thereof and intermediates therefor | TEXACO CHEMICAL COMPANY (US) | 1991-07-24 | — | — | EP | disclosed |
| US-5030754-A | Hydroxy-terminated substituted diurea derivatives | TEXACO CHEMICAL COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0418960-A2 | Nucleic acid detection method using unequal primer concentrations in polymerase chain reaction | EASTMAN KODAK COMPANY (US) | 1991-03-27 | — | — | EP | disclosed |
| US-4996315-A | Reacting polyalkylene glcyol monoamines with dicarboxylic acids in a 1:1 molar ratio | TEXACO CHEMICAL COMPANY (US) | 1991-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12498367-B2 | Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof | FCGR3B, FCGR2A, FCGR1A | MEN1 2002/4885KMT2A 2038/4885TSHR 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.